Glenmark Introduces 3-in-1 Inhaler Therapy for COPD in India, Promising Reduction in Risk of Severe Attacks and Improvement in Lung Function

New immunotherapy for lung cancer may be effective, safe: Lancet.....»»

Even low air pollution levels can up asthma risk.....»»

Beware! Ozone pollution may cause heart attack, high blood pressure, stroke.....»»

Twitter launches labels, warnings on misleading COVID-19 information.....»»

Evidence doesn#39;t indicate COVID-19 transmission risk from people discharged on revised criteria: Govt.....»»

Gold falls over 1% as dollar strengthens, lockdowns ease.....»»

Coronavirus pandemic | Gene therapy, select antivirals most promising for defeating COVID-19: Study.....»»

India battles supply snags in race to build affordable ventilators.....»»

As virus tears through reservation, Navajos give lifeline to elders and families.....»»

Experts urge smokers and tobacco firms to quit for COVID-19.....»»

Cipla gets USFDA nod for generic acid reflux drug.....»»

Indian rupee to average at 77 per US dollar in 2020, 80 in 2021: Fitch Solutions.....»»

Coronavirus pandemic: Dwindling inventory, supply chain disruption — India faces shortage of ventilators.....»»

SEBI tweaks framework for stock brokers#39; risk mgmt capabilities.....»»

Air quality remains severe in Delhi, slight improvement likely.....»»

FM Nirmala Sitharaman introduces bill in Lok Sabha to amend insolvency law.....»»

#39;Sentiment shared across country#39;: Congress attacks govt over Rahul Bajaj#39;s #39;atmosphere of fear#39; remark.....»»

Bharti Airtel share price fall 4% after ICRA rating downgrade.....»»

Axis Bank falls 3% despite reports of capital enhancement.....»»

U.S. cases of vaping-related illness rise to 530 as outbreak widens.....»»